Lonza - PBMCs

EDITORIAL SECTION

KNOWLEDGE BANK

TOP ARTICLES

press releasesRead more...

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia

Lkahi Therapeutics a subsidiary of Glucotrack Inc Nasdaq GCTK today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial

Scholar Rock NASDAQ SRRK a global biopharmaceutical company dedicated to improving the lives of patients with rare severe and debilitating neuromuscular diseases by applying its worldleading platform

United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation Nasdaq UTHR a public benefit corporation today announced that the FDA has accepted the supplemental New Drug Application sNDA for nebulized Tyvaso treprostinil

DnaK Therapeutics & GATC Health Forge A Partnership To Evaluate, Accelerate & Prioritize Cancer Drug Candidates Using AI Platform

DnaK Therapeutics and GATC Health Corp jointly announced today a collaboration to use GATCs proprietary artificial intelligence platform to evaluate and prioritize innovative potential cancer drug candidates

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

09 - 10

Sep 2026

iPSC Drug Development Summit

Hyatt Regency Boston Harbour,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

LATEST NEWSRead more...

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

EpiVax Inc has launched AIenhanced features for ISPRI its in silico platform for assessing the immunogenicity risk of biotherapeutics The update includes an improved JanusMatrix model

Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader

Thermo Fisher Scientific has launched the Thermo Scientific Multiskan Ease Absorbance Microplate Reader designed to simplify routine laboratory analysis involving proteins cells and microorganisms

Juniper Biosciences Receives FDA Breakthrough Therapy Designation for JBS-003

Juniper Biosciences has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for JBS Ffluoromisonidazole or FMISO a hypoxia tracer being developed to guide reduced radiation therapy in patients with HPVpositive oropharyngeal carcinoma OPC

FDA approves PharmaEssentia’s BESREMi for adults with essential thrombocythaemia

PharmaEssentia USA Corporation a subsidiary of PharmaEssentia Corporation has received approval from the US Food and Drug Administration FDA for BESREMi ropeginterferon alfabnjft to treat adults with essential thrombocythaemia ET a rare form of blood cancer

Transcat expands biomedical calibration business with Southeastern Biomedical acquisition

Transcat Inc has acquired privately held Southeastern Biomedical Associates Incorporated strengthening its biomedical calibration services and expanding its presence across the southeastern United States

FDA Approves Revolution Medicines’ RASONQUE for Metastatic Pancreatic Cancer

The US Food and Drug Administration FDA has approved Revolution Medicines RASONQUE daraxonrasib tablets for adults with metastatic pancreatic adenocarcinoma PDAC who have received at least one previous systemic treatment or are not candidates for multiagent systemic therapy